Facial Fat Transfer Market

The global facial fat transfer market will be worth more than USD 6.7 billion by 2033.

The expanding number of aesthetic treatments performed worldwide, as well as the fast-growing geriatric population, are driving the industry. In line with the data disclosed by the International Society for Aesthetic Plastic Surgery, there were approximately 10,607,227 cosmetic treatments conducted worldwide in 2018. Moreover, the amount of face fat grafting surgeries is expected to reach 542,305, accounting for around 5.1% of all procedures for cosmetic surgery. In addition, Wrinkles and sagging skin are intrinsically related to aging, typically caused by a loss of facial volume. According to the World Health Organization, around 125 million people were 80 years of age or older in 2018. As a result, the need for facial fat transfer will expand. A recent study published in the medical journal Plastic and Reconstructive Surgery, which is the official publication of the American Society of Plastic Surgeons, revealed that many plastic surgeons in the US have started using fat grafting techniques in facelift surgeries. Additionally, the availability of expedited approval for medical devices and systems enables advancements and breakthroughs in autologous fat grafting systems.

Market participants are seeking product development to grow their market share and establish traction in the global marketplace. Firms engage in strategic acquisitions such as product launches, R&D, collaborations, as well as partnerships to acquire market share. Companies are developing products related to face fat transfer, which is expected to drive the growth of the facial fat transfer market. For instance, In February 2019, Alma Lasers, Inc. is pleased to announce the launch of BeautiFill in North America, the first laser-based approach designed to optimize the method, time, and accuracy of autologous fat transfer for comprehensive aesthetic contouring. BeautiFill combines laser, suction, and fat processing into a single straightforward treatment that allows doctors to remove and process high-quality fat for rapid reimplantation to treat volume loss.

According to the CXOs and primary research conducted, the growing number of injuries caused by burns and accidents, the increased prevalence of skin problems, and lifestyle changes all present more potential for autologous fat grafting providers to expand. For instance, in December 2018, the FDA unveiled its vision for its "Breakthrough Devices Program," stating its goals for speeding the development of breakthrough diagnostic and treatment devices. Autologous fat grafting is a common procedure in reconstructive and cosmetic surgery. Between 2014 and 2018, the number of cosmetic fat grafting treatments increased by more than 48%.

The drone camera market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. In line with the analyzed region, the North American region will witness the highest market share, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. The rise of the facial fat transfer market in the Asia Pacific region is projected to be assisted by significant increases in the number of hospitals and expanding healthcare facilities. The Asia-Pacific market is predicted to grow significantly throughout the forecast period due to the high success rate of facial fat transfer procedures. The major companies operating within the market are Allergan Plc.; Bausch Health Companies Inc, Cytori Therapeutics Inc, DR.Korman, Galderma Laboratories L.P, Integra Lifesciences Corporation, Medikan International Inc, Stanford Biotech Inc, Teoxane Laboratories.

‍